Stem Cell Therapies
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
10
NCT03735277
Evaluation of the Safety and Efficacy of Hemacord HPC, Cord Blood in Subjects With Acute Ischemic Stroke
Phase: Phase 1
Role: Lead Sponsor
Start: Mar 6, 2021
Completion: Jul 31, 2022